The two companies will come together to provide a ‘patient-centered solution’ for clinical research, combing uMotif’s patient engagement platform with ActiGraph’s wearable technology.
One of the biggest questions being posed at this year's SCOPE summit, is whether the term 'decentralized clinical trials' will become redundant, as it forms the norm.
Steve Rosenberg has been a life science and healthcare executive for 40+ years and is currently CEO of uMotif. He commercialized the first integrated clinical technology suite at Phase Forward/Oracle. Top pharma and biotech executives depend on him for...
Caroline Jackson is executive vice president for patient services at mdgroup and she will be delivering a presentation at SCOPE called 'Achieving the Impossible: Maximizing Patient Experience and Data Quality in a Complex Rare Disease Program.'...
The Summit for Clinical Ops Executives (SCOPE) is back with a four-day schedule that digs into strategies and technologies for tackling the perpetual problem of patient recruitment.
In-home nurse visits, using familiar mobile devices to upload health data, and telemedicine calls with a doctor are the elements of decentralized clinical trials with the biggest positive impact on participation in future studies, according to a survey.
The companies will work together to help clients connect information sources, giving stakeholders a better overview of the clinical patient experience.
With the purchase, the company is looking to advance its plans to connect with potential trial participants and spread awareness of study participation.
A representative from the biometric contract research organization explains how taking a ‘patient comes first’ attitude can lead to a range of improvements.
A leader suggests considering patient views and needs all along the clinical development path reaps a number of benefits, including time and cost savings.
The group has introduced a downloadable guide, interactive quiz, and other tools to inform patients from underrepresented communities about trial participation.
A leader from the trial financial management specialist suggests apps used in trials could be adjusted to better suit patients, sites and other stakeholders.
An expert from the clinical insight specialist shares how predictive analytics could reveal info about medication adherence, disease progression, and more.
A leader from the behavioral science specialist shares ways to use precision engagement and other methods to increase patient adherence in clinical studies.
A survey by SubjectWell indicates that having Spanish-speaking research personnel increases interest in trial participation among Latino potential patients.
During the World Orphan Drug Congress, a co-founder of the CRO outlined how patient perspective can be vital to better results in rare-disease research.
Bridging the Gap for Clinical Trials is a free competition designed to employ artistic expression to dispel misinformation start positive conversations.
During the Decentralized Trial Technology event, experts from CVS Health, University of Chicago, and ACRP shared insight on what can increase DCT success.
A leader from the CRO discusses how capturing the perspective of trial participants can help ensure development of treatments that meet the patients’ needs.
The research institutions are joining on a community-based collaborative initiative to work toward greater study inclusion, supported by funding from PhRMA.
The Foundation for Sarcoidosis Research hosted more than 50 agency leaders in a session that addressed patient concerns in research, care, and diagnosis.
A pediatric clinical trial expert from the CRO discusses the unique challenges involved in designing a study when the patients involved are little ones.
Clinical Trial Navigator, from AmerisourceBergen, is designed to help sponsors pair with oncology practices to boost patient recruitment opportunities.
In this first of a two-part series, an expert discusses various factors behind the DCT format’s rapid rise and likely longevity in the drug development arena.
The pharmaceutical firm will work with the health tech company to create a digital therapeutic intended for patients dealing with a breast cancer diagnosis.
An expert from the decentralized trial solutions company shares how eCOA and ePRO can be useful tools that improve the collection and quality of such data.
The company has added Type 2 diabetes to the list of conditions it simulates in it’s A Life in a Day program, enabling people to spend a day living as if they have the disease.
The sponsorship from Janssen Pharmaceutical Companies will be used by the cancer support network to boost diversity in Phase I and Phase 2 clinical trials.
Parexel's Community Alliance Network, designed to more deeply integrate clinical research into community healthcare, has invited Javara and CVS as members
A leader from the site management organization, which already has expanded since opening in 2019, is planning on adding sites and talent to its roster.
Representatives from Clincierge, Rare Patient Voice, Insight and Measurement, and Ultragenyx Pharmaceutical will lead the lively panel discussion on June 13.
The June 20 Medical Heroes Appreciation 5k Run and Walk, scheduled during the DIA Global Annual Meeting in Chicago, salutes contributions of trial volunteers.
Through its Health Equity and Diversity in STEM Innovation Fund, the biotech is looking to increase equity in care and diversify the scientific workforce.
An expert from health data and analytics solutions provider H1 explains how technology can help address the disparities in clinical trial and care access.
An expert from the AI-focused technology company shares insights as to how it can be harnessed to better interpret, and even predict, patient behavior.
IllumiCare has added the app to its Smart Ribbon point-of-care information tool, enabling providers to connect patients to appropriate clinical studies.
The company’s analysis of 2.5m patients worldwide suggest a growing proportion of younger patients, with implications for future study design and deployment.
The cancer trial-matching company is partnering with MPN Research Foundation to help match patients with a group of rare blood cancers to clinical trials.
The two companies are forming a European Medical Advisory Committee to better connect patients and physicians, inviting other trial professionals to join in.
Leaders from the biotech company share advice on how such organizations can make the most of often limited resources via smart strategy and collaboration.
The clinical trial tech firm has announced a $220m Series D funding round which will boost its efforts to improve inclusivity and representation in studies.
The pharmaceutical firm and university have launched T-REX, a multi-year partnership focused on increasing health outcomes for underrepresented populations.
A leader from the life-science organization discusses how collaboration could lead to a broad range of benefits for everyone along the drug discovery pipeline
The Pancreatic Cancer Action Network has engaged five new clinical trial sites in the US, which will aid in evaluation of Novartis’ investigational therapy.
A leader from the patient recruitment specialist discusses the industry’s ongoing challenges with patient population diversity, and potential solutions.
While strides have been made recruiting more representative patient populations, more can and should be done, according to an Oracle Health Sciences leader.
A leader from the trial platform company discusses how patient experience can be enhanced when the clinical trial team shares a background with the subjects.